|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online November 10, 2004
doi: 10.1242/10.1242/jcs.01558
Commentary |
Department of Psychiatry, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA
* Author for correspondence (e-mail: gvwj{at}uab.edu)
Tau is a group of neuronal microtubule-associated proteins that are formed by alternative mRNA splicing and accumulate in neurofibrillary tangles in Alzheimer's disease (AD) brain. Tau plays a key role in regulating microtubule dynamics, axonal transport and neurite outgrowth, and all these functions of tau are modulated by site-specific phosphorylation. There is significant evidence that a disruption of normal phosphorylation events results in tau dysfunction in neurodegenerative diseases, such as AD, and is a contributing factor to the pathogenic processes. Indeed, the abnormal tau phosphorylation that occurs in neurodegenerative conditions not only results in a toxic loss of function (e.g. decreased microtubule binding) but probably also a toxic gain of function (e.g. increased tau-tau interactions). Although tau is phosphorylated in vitro by numerous protein kinases, how many of these actually phosphorylate tau in vivo is unclear. Identification of the protein kinases that phosphorylate tau in vivo in both physiological and pathological processes could provide potential therapeutic targets for the treatment of AD and other neurodegenerative diseases in which there is tau pathology.
Key words: Tau, Microtubules, Phosphorylation, Kinases, Alzheimer's disease
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
H.-H. Lee, L. Y. Jan, and Y.-N. Jan Drosophila IKK-related kinase Ik2 and Katanin p60-like 1 regulate dendrite pruning of sensory neuron during metamorphosis PNAS, April 14, 2009; 106(15): 6363 - 6368. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Amniai, P. Barbier, A. Sillen, J.-M. Wieruszeski, V. Peyrot, G. Lippens, and I. Landrieu Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules FASEB J, April 1, 2009; 23(4): 1146 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Wolfe Tau Mutations in Neurodegenerative Diseases J. Biol. Chem., March 6, 2009; 284(10): 6021 - 6025. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jeganathan, A. Hascher, S. Chinnathambi, J. Biernat, E.-M. Mandelkow, and E. Mandelkow Proline-directed Pseudo-phosphorylation at AT8 and PHF1 Epitopes Induces a Compaction of the Paperclip Folding of Tau and Generates a Pathological (MC-1) Conformation J. Biol. Chem., November 14, 2008; 283(46): 32066 - 32076. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Deshpande, K. M. Win, and J. Busciglio Tau isoform expression and regulation in human cortical neurons FASEB J, July 1, 2008; 22(7): 2357 - 2367. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Anderson, D. W. Hampton, R. Patani, G. Pryce, R. A. Crowther, R. Reynolds, R. J. M. Franklin, G. Giovannoni, D. A. S. Compston, D. Baker, et al. Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis Brain, July 1, 2008; 131(7): 1736 - 1748. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. He, Z. Hou, and R. Z. Qi Calmodulin Binding and Cdk5 Phosphorylation of p35 Regulate Its Effect on Microtubules J. Biol. Chem., May 9, 2008; 283(19): 13252 - 13260. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Terwel, D. Muyllaert, I. Dewachter, P. Borghgraef, S. Croes, H. Devijver, and F. Van Leuven Amyloid Activates GSK-3{beta} to Aggravate Neuronal Tauopathy in Bigenic Mice Am. J. Pathol., March 1, 2008; 172(3): 786 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-R. Ryoo, H. K. Jeong, C. Radnaabazar, J.-J. Yoo, H.-J. Cho, H.-W. Lee, I.-S. Kim, Y.-H. Cheon, Y. S. Ahn, S.-H. Chung, et al. DYRK1A-mediated Hyperphosphorylation of Tau: A FUNCTIONAL LINK BETWEEN DOWN SYNDROME AND ALZHEIMER DISEASE J. Biol. Chem., November 30, 2007; 282(48): 34850 - 34857. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Blard, S. Feuillette, J. Bou, B. Chaumette, T. Frebourg, D. Campion, and M. Lecourtois Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila Hum. Mol. Genet., March 1, 2007; 16(5): 555 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu, S. Rajareddy, P. Reddy, K. Jagarlamudi, C. Du, Y. Shen, Y. Guo, K. Boman, E. Lundin, U. Ottander, et al. Phosphorylation and inactivation of glycogen synthase kinase-3 by soluble kit ligand in mouse oocytes during early follicular development J. Mol. Endocrinol., January 1, 2007; 38(1): 137 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Clodfelder-Miller, A. A. Zmijewska, G. V.W. Johnson, and R. S. Jope Tau Is Hyperphosphorylated at Multiple Sites in Mouse Brain In Vivo After Streptozotocin-Induced Insulin Deficiency Diabetes, December 1, 2006; 55(12): 3320 - 3325. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C. Yang, C. H. Lin, and E. H. Y. Lee Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) Increases Neurite Formation through Microtubule Depolymerization by SGK1 and by SGK1 Phosphorylation of tau Mol. Cell. Biol., November 15, 2006; 26(22): 8357 - 8370. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cripps, S. N. Thomas, Y. Jeng, F. Yang, P. Davies, and A. J. Yang Alzheimer Disease-specific Conformation of Hyperphosphorylated Paired Helical Filament-Tau Is Polyubiquitinated through Lys-48, Lys-11, and Lys-6 Ubiquitin Conjugation J. Biol. Chem., April 21, 2006; 281(16): 10825 - 10838. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Qiang, W. Yu, A. Andreadis, M. Luo, and P. W. Baas Tau protects microtubules in the axon from severing by katanin. J. Neurosci., March 22, 2006; 26(12): 3120 - 3129. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Potel and G. Elliott Phosphorylation of the Herpes Simplex Virus Tegument Protein VP22 Has No Effect on Incorporation of VP22 into the Virus but Is Involved in Optimal Expression and Virion Packaging of ICP0 J. Virol., November 15, 2005; 79(22): 14057 - 14068. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Buttini, E. Masliah, R. Barbour, H. Grajeda, R. Motter, K. Johnson-Wood, K. Khan, P. Seubert, S. Freedman, D. Schenk, et al. {beta}-Amyloid Immunotherapy Prevents Synaptic Degeneration in a Mouse Model of Alzheimer's Disease J. Neurosci., October 5, 2005; 25(40): 9096 - 9101. [Abstract] [Full Text] [PDF] |
||||